Cited by 616Amyotrophic Lateral Sclerosis ResearchHereditary Neurological DisordersAlzheimer's disease research and treatments

The DOI matches its Crossref record; 201 of the 202 references it cites were found in a registry or an index.

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

Open access

Ferraiuolo, Laura, Kirby, Janine, Grierson, Andrew J., Sendtner, Michael, Shaw, Pamela J.·2011·Nature Reviews Neurology

DOI 10.1038/nrneurol.2011.152

Open this paper in CoChat — free account

Abstract

Amyotrophic lateral sclerosis (ALS) is a genetically diverse disease. At least 15 ALS-associated gene loci have so far been identified, and the causative gene is known in approximately 30% of familial ALS cases. Less is known about the factors underlying the sporadic form of the disease. The molecular mechanisms of motor neuron degeneration are best understood in the subtype of disease caused by mutations in superoxide dismutase 1, with a current consensus that motor neuron injury is caused by a complex interplay between multiple pathogenic processes. A key recent finding is that mutated TAR DNA-binding protein 43 is a major constituent of the ubiquitinated protein inclusions in ALS, providing a possible link between the genetic mutation and the cellular pathology. New insights have also indicated the importance of dysregulated glial cell-motor neuron crosstalk, and have highlighted the vulnerability of the distal axonal compartment early in the disease course. In addition, recent studies have suggested that disordered RNA processing is likely to represent a major contributing factor to motor neuron disease. Ongoing research on the cellular pathways highlighted in this Review is predicted to open the door to new therapeutic interventions to slow disease progression in ALS.

Integrity signals

Registry

Crossref · 10.1038/nrneurol.2011.152

Cites

201 of 201 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 retracted

RETRACTED: Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis
Atkin, J. D., Farg, M. A., Walker, A. K., McLean, C., Tomas, D., & Horne, M. K. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.009 · Cited by 350
Retracted
Induction of the Unfolded Protein Response in Familial Amyotrophic Lateral Sclerosis and Association of Protein-disulfide Isomerase with Superoxide Dismutase 1
Atkin, J. D., Farg, M. A., Turner, B. J., Tomas, D., Lysaght, J. A., Nunan, J., Rembach, A., Nagley, P., Beart, P. M., Cheema, S. S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603393200 · Cited by 289
Retracted
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citation
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Bénichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,995
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C. A., Rogelj, B., Hortobágyi, T., Vos, K. J. D., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B. N., Ruddy, D., Wright, P. D., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,625

Flagged first, then by citations

Show all 202 references

1 of the 202 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Fitzmaurice, P. S. et al. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 19, 797–798 (1996).
Highley, J. R. et al. TARDBP mutations, amyotrophic lateral sclerosis and alternative splicing in human fibroblasts. Brain Pathol. 20 (Suppl. 1), 32 (2010).

Sorted by citations

Items 301–400 of 616

Screening of the TARDBP gene in familial and sporadic amyotrophic lateral sclerosis patients of Chinese origin
Zou, Z., Yu, P., Wang, X., Liu, M., Li, X., & Cui, L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.014 · Cited by 26
Cellular Redox Systems Impact the Aggregation of Cu,Zn Superoxide Dismutase Linked to Familial Amyotrophic Lateral Sclerosis
Álvarez-Zaldiernas, C., Lu, J., Zheng, Y., Yang, H., Blasi, J., Solsona, C., & Holmgren, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.708230 · Cited by 27
Genomic variants in the FTO gene are associated with sporadic amyotrophic lateral sclerosis in Greek patients
Mitropoulos, K. A., Papadima, E. M., Xiromerisiou, G., Balasopoulou, A., Charalampidou, K., Galani, V., Zafeiri, K.-V., Dardiotis, E., Ralli, S., Deretzi, G., et al. (2017) · Human Genomics · doi:10.1186/s40246-017-0126-2 · Cited by 28
Genotype-Property Patient-Phenotype Relations Suggest that Proteome Exhaustion Can Cause Amyotrophic Lateral Sclerosis
Kepp, K. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118649 · Cited by 24
Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach
Morello, G., Spampinato, A. G., Conforti, F. L., D’Agata, V., & Cavallaro, S. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0898-9 · Cited by 25
PTEN regulates AMPA receptor-mediated cell viability in iPS-derived motor neurons
Yang, D., Wang, X.-L., Ismail, A., Ashman, C. J., Valori, C. F., Wang, G., Gao, S., Higginbottom, A., Ince, P. G., Azzouz, M., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.55 · Cited by 25
Self-citation
ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis
Jablonski, M., Miller, D. S., Pasinelli, P., & Trotti, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.08.060 · Cited by 25
Overexpression of nuclear FUS induces neuronal cell death
Suzuki, H., & Matsuoka, M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.007 · Cited by 25
The Wobbler Mouse Model of Amyotrophic Lateral Sclerosis (ALS) Displays Hippocampal Hyperexcitability, and Reduced Number of Interneurons, but No Presynaptic Vesicle Release Impairments
Thielsen, K. D., Moser, J., Schmitt‐John, T., Jensen, M. S., Jensen, K., & Holm, M. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082767 · Cited by 25
Protein Disulphide Isomerases: emerging roles of PDI and ERp57 in the nervous system and as therapeutic targets for ALS
Perri, E. R., Parakh, S., & Atkin, J. D. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1254197 · Cited by 26
Could sirtuin activities modify ALS onset and progression?
Tang, B. L. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0452-2 · Cited by 24
RNA-targeted Therapeutics for ALS
Reddy, L. V., & Miller, T. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0344-z · Cited by 26
Dysregulated axonal RNA translation in amyotrophic lateral sclerosis
Yasuda, K., & Mili, S. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1352 · Cited by 27
Elucidation of Relevant Neuroinflammation Mechanisms Using Gene Expression Profiling in Patients with Amyotrophic Lateral Sclerosis
Won, Y. H., Lee, M.-Y., Choi, Y., Ha, Y., Kim, S., ‍Kim, D. Y., Kim, M., Yu, J. H., Seo, J. H., Kim, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165290 · Cited by 24
Mitochondriomics reveals the underlying neuroprotective mechanism of TrkB receptor agonist R13 in the 5×FAD mice
Li, T., Li, X., Huang, X., Yu, H., Li, S., Zhang, Z., Xie, Y., Song, X., Liu, J., Yang, X., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108899 · Cited by 24
Inhibition of Cytohesins Protects against Genetic Models of Motor Neuron Disease
Zhai, J., Zhang, L., Mojsilovic‐Petrovic, J., Jian, X., Thomas, J., Homma, K., Schmitz, A., Famulok, M., Ichijo, H., Argon, Y., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5032-13.2015 · Cited by 24
Advances in Cellular Models to Explore the Pathophysiology of Amyotrophic Lateral Sclerosis
Veyrat‐Durebex, C., Corcia, P., Dangoumau, A., Laumonnier, F., Piver, É., Gordon, P. H., Andres, C. R., Vourc’h, P., & Blasco, H. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8573-9 · Cited by 28
Amyotrophic Lateral Sclerosis-Linked Mutant VAPB Inclusions Do Not Interfere with Protein Degradation Pathways or Intracellular Transport in a Cultured Cell Model
Genevini, P., Papiani, G., Ruggiano, A., Cantoni, L., Navone, F., & Borgese, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113416 · Cited by 24
Neuroprotective Role of the Basic Leucine Zipper Transcription Factor NFIL3 in Models of Amyotrophic Lateral Sclerosis
Tamai, S.-I., Imaizumi, K., Kurabayashi, N., Nguyen, M. D., Abe, T., Inoue, M., Fukada, Y., & Sanada, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.524389 · Cited by 22
Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases
Cascella, R., Fani, G., Bigi, A., Chiti, F., & Cecchi, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153685 · Cited by 25
Stem cells for amyotrophic lateral sclerosis modeling and therapy: Myth or fact?
Coatti, G. C., Beccari, M. S., Olávio, T. R., Mitne‐Neto, M., Okamoto, O. K., & Zatz, M. (2015) · Cytometry Part A · doi:10.1002/cyto.a.22630 · Cited by 23
Catching a killer: Mechanisms of programmed cell death and immune activation in Amyotrophic Lateral Sclerosis
Neel, D. V., Basu, H., Gunner, G., & Chiu, I. M. (2022) · Immunological Reviews · doi:10.1111/imr.13083 · Cited by 22
Unlike Physical Exercise, Modified Environment Increases the Lifespan of SOD1G93A Mice However Both Conditions Induce Cellular Changes
Gerber, Y. N., Sabourin, J.-C., Hugnot, J., & Perrin, F. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045503 · Cited by 26
Toward precision medicine in amyotrophic lateral sclerosis.
Zou, Z., Liu, C.-Y., Che, C., & Huang, H. (2016) · PubMed · doi:10.3978/j.issn.2305-5839.2016.01.16 · Cited by 24
The Spatiotemporal Pattern of Degeneration in the Cerebellum of the Wobbler Mouse
Saberi, D., Ott, B., Dahlke, C., Matschke, V., Schmitt‐John, T., & Theiß, C. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw005 · Cited by 23
Healing of Amyotrophic Lateral Sclerosis: A Case Report
Mangelsdorf, I., Walach, H., & Mutter, J. (2017) · Complementary Medicine Research · doi:10.1159/000477397 · Cited by 23
Inactivation of the CB2 receptor accelerated the neuropathological deterioration in TDP‐43 transgenic mice, a model of amyotrophic lateral sclerosis
Rodríguez‐Cueto, C., Gómez‐Almería, M., García‐Toscano, L., Romero, J., Hillard, C. J., de Lago, E., & Fernández‐Ruíz, J. (2021) · Brain Pathology · doi:10.1111/bpa.12972 · Cited by 22
Genetic architecture of motor neuron diseases
Chaudhary, R., Agarwal, V., Rehman, M., Kaushik, A. S., & Mishra, V. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120099 · Cited by 24
Update on the pathological roles of prostaglandin E2 in neurodegeneration in amyotrophic lateral sclerosis
Nango, H., Tsuruta, K., Miyagishi, H., Aono, Y., Saigusa, T., & Kosuge, Y. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00366-w · Cited by 24
Natural Compounds Used as Therapies Targeting to Amyotrophic Lateral Sclerosis
Nabavi, S. F., Daglia, M., D’Antona, G., Sobarzo‐Sánchez, E., Talas, Z., & Nabavi, S. F. (2015) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201016666150118132224 · Cited by 22
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis
Bonifacino, T., Provenzano, F., Gallia, E., Ravera, S., Torazza, C., Bossi, S., Ferrando, S., Puliti, A., Bosch, L. V. D., Bonanno, G., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.05.007 · Cited by 22
Generation of Cellular Reactive Oxygen Species by Activation of the EP2 Receptor Contributes to Prostaglandin E2-Induced Cytotoxicity in Motor Neuron-Like NSC-34 Cells
Kosuge, Y., Nango, H., Kasai, H., Yanagi, T., Mawatari, T., Nishiyama, K., Miyagishi, H., Ishige, K., & Ito, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6101838 · Cited by 22
Neuritogenic Militarinone‐Inspired 4‐Hydroxypyridones Target the Stress Pathway Kinase MAP4K4
Schröder, P., Förster, T., Kleine, S., Becker, C. J., Richters, A., Ziegler, S., Rauh, D., Kumar, K., & Waldmann, H. (2015) · Angewandte Chemie · doi:10.1002/ange.201501515 · Cited by 22
Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation
Röderer, P., Klatt, L., John, F., Theis, V., Winklhofer, K. F., Theiß, C., & Matschke, V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0999-7 · Cited by 22
USP5/Leon deubiquitinase confines postsynaptic growth by maintaining ubiquitin homeostasis through Ubiquilin
Wang, C.-H., Huang, Y., Chen, P., Cheng, Y.-J., Kao, H.-H., Pi, H., & Chien, C. (2017) · eLife · doi:10.7554/elife.26886 · Cited by 20
New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis
Pampalakis, G., Mitropoulos, K. A., Xiromerisiou, G., Dardiotis, E., Deretzi, G., Anagnostouli, M. C., Κάτσιλα, Θ., Rentzos, M., & Patrinos, G. P. (2018) · Human Mutation · doi:10.1002/humu.23697 · Cited by 20
Concomitant gain and loss of function pathomechanisms in C9ORF72 amyotrophic lateral sclerosis
Pal, A., Kretner, B., Abo-Rady, M., Glaβ, H., Dash, B. P., Naumann, M., Japtok, J., Kreiter, N., Dhingra, A., Heutink, P., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000764 · Cited by 24
Elevated mRNA-levels of distinct mitochondrial and plasma membrane Ca2+ transporters in individual hypoglossal motor neurons of endstage SOD1 transgenic mice
hling, T. M. ⁄., Duda, J., Weishaupt, J. H., Ludolph, A. C., & Liss, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00353 · Cited by 21
Longitudinal assessment of metal concentrations and copper isotope ratios in the G93A SOD1 mouse model of amyotrophic lateral sclerosis
Enge, T. G., Ecroyd, H. W., Jolley, D. F., Yerbury, J. J., & Dosseto, A. (2016) · Metallomics · doi:10.1039/c6mt00270f · Cited by 22
Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14-3-3-mediated cell survival by sequestration into the JUNQ compartment
Park, J.-H., Jang, H. R., Lee, I. Y., Oh, H. K., Choi, E., Rhim, H., & Kang, S. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx250 · Cited by 21
An oligomer-specific antibody improved motor function and attenuated neuropathology in the SOD1-G93A transgenic mouse model of ALS
Dong, Q.-X., Zhu, J., Liu, S., Yu, X., & Liu, R. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.032 · Cited by 21
Influence of selenium on the emergence of neuro tubule defects in a neuron-like cell line and its implications for amyotrophic lateral sclerosis
Maraldi, T., Beretti, F., Anselmi, L., Franchin, C., Arrigoni, G., Braglia, L., Mandrioli, J., Vinceti, M., & Marmiroli, S. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.09.015 · Cited by 21
Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis
Clark, C. M., Clark, R. M., Hoyle, J. A., & Dickson, T. C. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15125 · Cited by 20
Cellular Stress in the Pathogenesis of Muscular Disorders—From Cause to Consequence
Mensch, A., & Zierz, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165830 · Cited by 21
In a search for efficient treatment for amyotrophic lateral sclerosis: Old drugs for new approaches
Kukharsky, M. S., Skvortsova, V. I., Бачурин, С. О., & Buchman, V. L. (2020) · Medicinal Research Reviews · doi:10.1002/med.21725 · Cited by 21
Implementation of a manual for working with wobbler mice and criteria for discontinuation of the experiment
Ott, B., Dahlke, C., Meller, K., Napirei, M., Schmitt‐John, T., Brand‐Saberi, B., Theiß, C., & Saberi, D. (2015) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2015.03.007 · Cited by 21
Oligomerization of Cu,Zn-Superoxide Dismutase (SOD1) by Docosahexaenoic Acid and Its Hydroperoxides In Vitro: Aggregation Dependence on Fatty Acid Unsaturation and Thiols
Appolinário, P. P., Medinas, D. B., Chaves‐Filho, A. B., Genaro‐Mattos, T. C., Cussiol, J. R. R., Netto, L. E. S., Augusto, O., & Miyamoto, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125146 · Cited by 20
A Crucial Role for the Protein Quality Control System in Motor Neuron Diseases
Cristofani, R., Crippa, V., Cicardi, M. E., Tedesco, B., Ferrari, V., Chierichetti, M., Casarotto, E., Piccolella, M., Messi, E., Galbiati, M., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00191 · Cited by 24
The non-cell-autonomous component of ALS: new in vitro models and future challenges
Ferraiuolo, L. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140168 · Cited by 21
Self-citation
Transcriptional Analysis Reveals Distinct Subtypes in Amyotrophic Lateral Sclerosis: Implications for Personalized Therapy
Morello, G., & Cavallaro, S. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.60 · Cited by 20
Increased Expression of 15-Hydroxyprostaglandin Dehydrogenase in Spinal Astrocytes During Disease Progression in a Model of Amyotrophic Lateral Sclerosis
Miyagishi, H., Kosuge, Y., Takano, A., Endo, M., Nango, H., Yamagata-Murayama, S., Hirose, D., Kano, R., Tanaka, Y., Ishige, K., et al. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0377-9 · Cited by 20
Increased ROS‐Dependent Fission of Mitochondria Causes Abnormal Morphology of the Cell Powerhouses in a Murine Model of Amyotrophic Lateral Sclerosis
Stein, J., Walkenfort, B., Cihankaya, H., Hasenberg, M., Bader, V., Winklhofer, K. F., Röderer, P., Matschke, J., Theiß, C., & Matschke, V. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6924251 · Cited by 21
ALS-FUS mutations cause abnormal PARylation and histone H1.2 interaction, leading to pathological changes
Alirzayeva, H., Loureiro, R., Koyuncu, S., Hommen, F., Nabawi, Y., Zhang, W., Dao, T. T. P., Wehrmann, M., Lee, H. J., & Vı́lchez, D. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114626 · Cited by 18
The transcription factor Nurr1 is up-regulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice
Valsecchi, V., Boido, M., Montarolo, F., Guglielmotto, M., Perga, S., Martire, S., Cutrupi, S., Iannello, A., Gionchiglia, N., Signorino, E., et al. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.043513 · Cited by 19
The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death
Suzuki, H., & Matsuoka, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.737171 · Cited by 19
Yeast genetic interaction screen of human genes associated with amyotrophic lateral sclerosis: identification of MAP2K5 kinase as a potential drug targetPreprint
Jo, M., Chung, A. Y., Yachie, N., Seo, M., Jeon, H., Nam, Y., Seo, Y., Kim, E., Zhong, Q., Vidal, M., et al. (2017) · Genome Research · doi:10.1101/gr.211649.116 · Cited by 18
Neurotrophe Naturstoffe – ihre Chemie und Biologie
Xu, J., Lacoske, M. H., & Theodorakis, E. A. (2013) · Angewandte Chemie · doi:10.1002/ange.201302268 · Cited by 18
High-throughput drug screens for amyotrophic lateral sclerosis drug discovery
McGown, A., & Stopford, M. J. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1533953 · Cited by 17
A promise for neuronal repair: reprogramming astrocytes into neurons in vivo
Huang, L., Lai, X., Liang, X., Chen, J., Yang, Y., Xu, W., Qin, Q., Qin, R., Huang, X., Xie, M., et al. (2024) · Bioscience Reports · doi:10.1042/bsr20231717 · Cited by 18
Mahogunin ring finger 1 confers cytoprotection against mutant SOD1 aggresomes and is defective in an ALS mouse model
Chhangani, D., Endo, F., Amanullah, A., Upadhyay, A., Watanabe, S., Mishra, R., Yamanaka, K., & Mishra, A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.11.017 · Cited by 18
Gene expression profile of SOD1-G93A mouse spinal cord, blood and muscle
Saris, C. G. J., Groen, E. J. N., van Vught, P. W. J., van Es, M. A., Blauw, H. M., Veldink, J. H., & van den Berg, L. H. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2012.749914 · Cited by 18
Aldehyde Dehydrogenases 1A2 Expression and Distribution are Potentially Associated with Neuron Death in Spinal Cord of Tg(SOD1*G93A)1Gur Mice
Liang, H., Wu, C., Deng, Y., Zhu, L., Zhang, J., Gan, W., Tang, C., & Xu, R. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.19150 · Cited by 18
Early Detection of Motor Dysfunction in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis (ALS) Using Home Cage Running Wheels
Bennett, E., Mead, R. J., Azzouz, M., Shaw, P. J., & Grierson, A. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107918 · Cited by 18
Self-citation
Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics
Watts, M. E., Wu, C., & Rubin, L. L. (2019) · Journal of Experimental Neuroscience · doi:10.1177/1179069519862798 · Cited by 17
Human iPSC-Derived MSCs induce neurotrophic effects and improve metabolic activity in acute neuronal injury models
Kawatani, K., Omana Suarez, G., Perkerson, R. B., Parent, E. E., Nambara, T., Knight, J. A., Parsons, T. M., Gupta, K., Shue, F., Alnobani, A., et al. (2025) · The Journal of Neuroscience · doi:10.1523/jneurosci.0606-24.2024 · Cited by 18
Adaptation to Turkish and Reliability Study of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R)
Koç, F., Balal, M., Demir, T., Alparslan, Z. N., & Sarıca, Y. (2016) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2016.11334 · Cited by 17
Motor neurons derived from ALS-related mouse iPS cells recapitulate pathological features of ALS
Park, J.-H., Park, H.-S., Hong, S., & Kang, S. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.113 · Cited by 17
Expression and Distribution of Arylsulfatase B are Closely Associated with Neuron Death in SOD1 G93A Transgenic Mice
Zhang, J., Liang, H., Zhu, L., Gan, W., Tang, C., Li, J., & Xu, R. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0406-9 · Cited by 17
Intrathecal Injection of scAAV9–hIGF1 Prolongs the Survival of ALS Model Mice by Inhibiting the NF-kB Pathway
Hu, H., Lin, H., Duan, W., Cui, C., Li, Z., Liu, Y., Wang, W., Wen, D., Wang, Y., & Li, C. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.004 · Cited by 17
In vivo Direct Conversion of Astrocytes to Neurons Maybe a Potential Alternative Strategy for Neurodegenerative Diseases
Wang, Y., Zhang, X., Chen, F., Song, N., & Xie, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.689276 · Cited by 18
Endocannabinoids and amyotrophic lateral sclerosis
de Lago, E., Moreno‐Martet, M., Espejo‐Porras, F., & Fernández‐Ruíz, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417041-4.00005-9 · Cited by 17
Diseases of the nervous system
Nesterova, A. P., Климов, Е. А., Zharkova, M. S., Sozin, S., Sobolev, V. V., Ivanikova, N. V., Shkrob, M., & Yuryev, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817086-1.00005-1 · Cited by 17
MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approaches
Peplow, P., & Martinez, B. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.322431 · Cited by 16
Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis
Jeon, G. S., Im, W., Shim, Y., Lee, M., Kim, M.-J., Hong, Y., Seong, S., Kim, M., & Sung, J. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1774-z · Cited by 16
Improved Lentiviral Transduction of ALS Motoneurons in Vivo via Dual Targeting
O’Leary, V. B., Ovsepian, S. V., Bodeker, M., & Dolly, J. O. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400247t · Cited by 16
USP14 inhibition enhances Parkin-independent mitophagy in iNeurons
Bernardo, G., Prado, M. A., Dashtmian, A. R., Favaro, M., Mauri, S., Borsetto, A., Marchesan, E., Paulo, J. A., Gygi, S. P., Finley, D. J., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107484 · Cited by 16
Mitochondrial Redox Signaling Is Critical to the Normal Functioning of the Neuronal System
Odnokoz, O., Nakatsuka, K., Wright, C., Castellanos, J., Klichko, V. I., Kretzschmar, D., Orr, W. C., & Radyuk, S. N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.613036 · Cited by 16
Poor Corticospinal Motor Neuron Health Is Associated with Increased Symptom Severity in the Acute Phase Following Repetitive Mild TBI and Predicts Early ALS Onset in Genetically Predisposed Rodents
Alkaslasi, M. R., Cho, N., Dhillon, N. K., Shelest, O., Haro, P. S., Linaval, N. T., Ghoulian, J., Yang, A. R., Vit, J., Avalos, P., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11020160 · Cited by 15
Pathological characteristics of axons and alterations of proteomic and lipidomic profiles in midbrain dopaminergic neurodegeneration induced by WDR45-deficiency
Wang, P., Shao, Y., Al‐Nusaif, M., Zhang, J., Yang, H., Yang, Y., Kim, K., Li, S., Liu, C., Cai, H., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00746-4 · Cited by 20
Computational and Functional Characterization of Angiogenin Mutations, and Correlation with Amyotrophic Lateral Sclerosis
Padhi, A. K., Banerjee, K., Gomes, J., & Banerjee, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111963 · Cited by 15
Rofecoxib Attenuates the Pathogenesis of Amyotrophic Lateral Sclerosis by Alleviating Cyclooxygenase-2-Mediated Mechanisms
Zou, Y.-H., Guan, P.-P., Zhang, S.-Q., Guo, Y., & Wang, P. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00817 · Cited by 15
Little Helpers or Mean Rogue—Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis
Cihankaya, H., Theiß, C., & Matschke, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030993 · Cited by 16
H63DHFEpolymorphisms are associated with increased disease duration and decreased muscle superoxide dismutase-1 expression in amyotrophic lateral sclerosis patients
Su, X., Lee, S. Y., Mitchell, R. M., Stephens, H., Simmons, Z., & Connor, J. R. (2012) · Muscle & Nerve · doi:10.1002/mus.23740 · Cited by 15
Growth Differentiation Factor 6 As a Putative Risk Factor in Neuromuscular Degeneration
DuVal, M. G., Gilbert, M. J. H., Watson, D. E., Zerulla, T. C., Tierney, K. B., & Allison, W. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089183 · Cited by 15
Characterization of Motor Neuron Prostaglandin E2 EP3 Receptor Isoform in a Mouse Model of Amyotrophic Lateral Sclerosis
Kosuge, Y., Miyagishi, H., Shinomiya, T., Nishiyama, K., Suzuki, S., Osada, N., Ishige, K., Okubo, M., Kawaguchi, M., & Ito, Y. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00418 · Cited by 15
Emerging Ferroptosis Involvement in Amyotrophic Lateral Sclerosis Pathogenesis: Neuroprotective Activity of Polyphenols
Russo, A., Putaggio, S., Tellone, E., Calderaro, A., Cirmi, S., Laganà, G., Ficarra, S., Barreca, D., & Patanè, G. T. (2025) · Molecules · doi:10.3390/molecules30061211 · Cited by 18
A random set scoring model for prioritization of disease candidate genes using protein complexes and data-mining of GeneRIF, OMIM and PubMed records
Jiang, L., Edwards, S. M., Thomsen, B., Workman, C. T., Guldbrandtsen, B., & Sørensen, P. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-315 · Cited by 14
Ca2+ dysregulation in the pathogenesis of amyotrophic lateral sclerosis
Tedeschi, V., Petrozziello, T., & Secondo, A. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.014 · Cited by 14
Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders
Kumar, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010152 · Cited by 15
The metabolic intersection between immunosenescence and neuroinflammation in amyotrophic lateral sclerosis
Tsang, V. S. K., Malaspina, A., & Henson, S. M. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00460-y · Cited by 14
Generation of engineered human spinal cord organoid in channel-patterned collagen and transplantation for spinal cord regeneration
Ma, L., Zhang, Z., Mu, Y., Liu, B., Jin, M. Y., Ma, C., Zhou, H., Zhang, Y., & Wang, D. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123753 · Cited by 13
Insights on the Multifaceted Roles of Wild-Type and Mutated Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis Pathogenesis
Rubino, V., Rosa, G. L., Pipicelli, L., Carriero, F., Damiano, S., Santillo, M., Terrazzano, G., Ruggiero, G., & Mondola, P. (2023) · Antioxidants · doi:10.3390/antiox12091747 · Cited by 14
Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate‐length CAG repeat expansions in Ataxin‐2 does not have 1 C 2‐positive polyglutamine inclusions
Highley, J. R., Lorente-Pons, A., Cooper‐Knock, J., Wharton, S. B., Ince, P. G., Shaw, P. J., Wood, J. D., & Kirby, J. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12254 · Cited by 12
Self-citation
Pathophysiological role of prostaglandin E2-induced up-regulation of the EP2 receptor in motor neuron-like NSC-34 cells and lumbar motor neurons in ALS model mice
Kosuge, Y., Miyagishi, H., Yoneoka, Y., Yoneda, K., Nango, H., Ishige, K., & Ito, Y. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.06.013 · Cited by 13
Insights into the role of d ‐amino acid oxidase mutations in amyotrophic lateral sclerosis
Padhi, A. K., & Hazra, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27529 · Cited by 13
Combined intramuscular and intraspinal transplant of bone marrow cells improves neuromuscular function in the SOD1G93A mice
Martínez‐Muriana, A., Pastor, D., Mancuso, R., Rando, A., Osta, R., Martı́nez, S., López‐Vales, R., & Navarro, X. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-1573-6 · Cited by 13
Sulfinylation on Superoxide Dismutase 1 Cys111: Novel Mechanism for 1‐Nitropyrene to Promote Acute Reactive Oxygen Species Generation
Xie, G., Zhu, L., Zhang, Y., Song, Y., Zhang, H., Yang, Z., & Cai, Z. (2021) · Small Structures · doi:10.1002/sstr.202000123 · Cited by 13
Single-cell RNAseq analysis of spinal locomotor circuitry in larval zebrafish
Kelly, J. J., Wen, H., & Brehm, P. (2023) · eLife · doi:10.7554/elife.89338 · Cited by 14
Case-control study of environmental toxins and risk of amyotrophic lateral sclerosis involving the national ALS registry
Talbott, E. O., Malek, A. M., Arena, V. C., Wu, F., Steffes, K., Sharma, R. K., Buchanich, J. M., Rager, J. R., Bear, T., Hoffman, C. A., et al. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2336108 · Cited by 12
Insights into the role of ribonuclease 4 polymorphisms in amyotrophic lateral sclerosis
Padhi, A. K., Narain, P., Dave, U., Satija, R., Patir, A., & Gomes, J. (2017) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1419147 · Cited by 12

Authors: Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., & Shaw, P. J.
Affiliations: University of Sheffield (GB)
University of Würzburg (DE)
Corresponding author: Shaw, Pamela J.
ORCID: Ferraiuolo, Laura
Kirby, Janine
Grierson, Andrew J.
Sendtner, Michael
Shaw, Pamela J.
Venue: Nature Reviews Neurology
Publisher: Springer Science and Business Media LLC
Published: 2011-11
Volume: 7
Issue: 11
Pages: 616-630
ISSN: 1759-4758 (ISSN-L)
1759-4766
DOI: 10.1038/nrneurol.2011.152
OpenAlex: W2025413109
Cited by: 615
References: 202
Citations by year: 2026: 12 · 2025: 24 · 2024: 34 · 2023: 25 · 2022: 27 · 2021: 54 · 2020: 34 · 2019: 37 · 2018: 33 · 2017: 42 · 2016: 58 · 2015: 63 · 2014: 63 · 2013: 64 · 2012: 45
FWCI: 6.83
Type: journal article
Language: en
Open access: green
zenodo.org
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: Nature Reviews Neurology (publishedVersion)
PubMed (publishedVersion)
Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
Funders: Wellcome Trust
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: amyotrophic lateral sclerosis, motor neuron injury, motor neuron degeneration, oxidative stress, mitochondrial dysfunction, excitotoxicity, superoxide dismutase 1, TDP-43, sporadic ALS, familial ALS, therapeutic target
MeSH terms: Amyotrophic Lateral Sclerosis, Humans, Motor Neurons, Nerve Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks